Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Borah

Showing results (131-140 of 223) with videos related to

Pageof 23
Sort By:
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|March 15, 2021
Impact of Pharmacogenomic Information on Values of Care and Quality of Life Associated with Codeine and Tramadol-Related Adverse Drug EventsYe Zhu, Guilherme S Lopes, Suzette J Bielinski, et al.
Plos One|May 20, 2020
Comparing outcomes and costs among warfarin-sensitive patients versus warfarin-insensitive patients using The Right Drug, Right Dose, Right Time: Using genomic data to individualize treatment (RIGHT) 10K warfarin cohortKristi M Swanson, Ye Zhu, Ricardo L Rojas, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|September 19, 2018
Risk Factors Associated With Health Care Utilization and Costs of Patients Undergoing Lower Extremity Joint ReplacementMeghan A Knoedler, Molly M Jeffery, Lindsey M Philpot, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 12, 2023
Yttrium-90 Ibritumomab Tiuxetan is Cost-Effective Compared to Bendamustine + Rituximab in Low-grade LymphomasMuhamad Alhaj Moustafa, Bijan J Borah, James P Moriarty, et al.
Journal of Shoulder and Elbow Surgery|March 9, 2020
Cost analysis and complication profile of primary shoulder arthroplasty at a high-volume institutionJustin C Kennon, Chad E Songy, Erick Marigi, et al.
Cancer|October 17, 2022
Comparative cost-effectiveness of neoadjuvant chemotherapy regimens for muscle-invasive bladder cancer: Results according to VESPER dataDaniel D Joyce, Kevin M Wymer, Vidit Sharma, et al.
Learning Health Systems|October 21, 2024
Overcoming challenges in real-world evidence generation: An example from an Adult Medical Care Coordination programSamuel T Savitz, Michelle A Lampman, Shealeigh A Inselman, et al.
The American Journal of Gastroenterology|June 16, 2021
Comparative Cost Effectiveness of Reflux-Based and Reflux-Independent Strategies for Barrett's Esophagus ScreeningSarmed S Sami, James P Moriarty, Jordan K Rosedahl, et al.
The Journal of Urology|March 20, 2020
Cost-Effectiveness of Maintenance bacillus Calmette-Guérin for Intermediate and High Risk Nonmuscle Invasive Bladder CancerVidit Sharma, Kevin M Wymer, Bijan J Borah, et al.
Hepatology Communications|February 7, 2018
Incidence and cost analysis of hospital admission and 30-day readmission among patients with cirrhosisSakkarin Chirapongsathorn, Chayakrit Krittanawong, Felicity T Enders, et al.
Pageof 23

Showing results (131-140 of 223) with videos related to

Sort By:
Pageof 23
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|March 15, 2021
Impact of Pharmacogenomic Information on Values of Care and Quality of Life Associated with Codeine and Tramadol-Related Adverse Drug EventsYe Zhu, Guilherme S Lopes, Suzette J Bielinski, et al.
Plos One|May 20, 2020
Comparing outcomes and costs among warfarin-sensitive patients versus warfarin-insensitive patients using The Right Drug, Right Dose, Right Time: Using genomic data to individualize treatment (RIGHT) 10K warfarin cohortKristi M Swanson, Ye Zhu, Ricardo L Rojas, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|September 19, 2018
Risk Factors Associated With Health Care Utilization and Costs of Patients Undergoing Lower Extremity Joint ReplacementMeghan A Knoedler, Molly M Jeffery, Lindsey M Philpot, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 12, 2023
Yttrium-90 Ibritumomab Tiuxetan is Cost-Effective Compared to Bendamustine + Rituximab in Low-grade LymphomasMuhamad Alhaj Moustafa, Bijan J Borah, James P Moriarty, et al.
Journal of Shoulder and Elbow Surgery|March 9, 2020
Cost analysis and complication profile of primary shoulder arthroplasty at a high-volume institutionJustin C Kennon, Chad E Songy, Erick Marigi, et al.
Cancer|October 17, 2022
Comparative cost-effectiveness of neoadjuvant chemotherapy regimens for muscle-invasive bladder cancer: Results according to VESPER dataDaniel D Joyce, Kevin M Wymer, Vidit Sharma, et al.
Learning Health Systems|October 21, 2024
Overcoming challenges in real-world evidence generation: An example from an Adult Medical Care Coordination programSamuel T Savitz, Michelle A Lampman, Shealeigh A Inselman, et al.
The American Journal of Gastroenterology|June 16, 2021
Comparative Cost Effectiveness of Reflux-Based and Reflux-Independent Strategies for Barrett's Esophagus ScreeningSarmed S Sami, James P Moriarty, Jordan K Rosedahl, et al.
The Journal of Urology|March 20, 2020
Cost-Effectiveness of Maintenance bacillus Calmette-Guérin for Intermediate and High Risk Nonmuscle Invasive Bladder CancerVidit Sharma, Kevin M Wymer, Bijan J Borah, et al.
Hepatology Communications|February 7, 2018
Incidence and cost analysis of hospital admission and 30-day readmission among patients with cirrhosisSakkarin Chirapongsathorn, Chayakrit Krittanawong, Felicity T Enders, et al.
Pageof 23